The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Traxam 3 %w/w Gel

Amdipharm LimitedPA1142/025/001

Main Information

Trade NameTraxam 3 %w/w Gel
Active SubstancesFelbinac
Dosage FormGel
Licence HolderAmdipharm Limited
Licence NumberPA1142/025/001

Group Information

ATC CodeM02AA Antiinflammatory preparations, non-steroids for topical use
M02AA08 felbinac


License statusAuthorised
Licence Issued06/10/1987
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back